Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived— vs Q4 2017 Net Income-$33.00K-$33.00KderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$8,000N/M Operating Cash Flowderived-$8,000N/M ended Feb 28, 2019 · filed Jun 12, 2019 · 104 d after period end